MAPS’ Phase 3 study of MDMA-assisted therapy was published in Nature Medicine on Monday, with a flurry of mainstream media attention following thereafter. In fact, the news adorned the front page of the New York Times’ print edition on Monday, with the headline: Psychedelics Are Poised to Reshape Psychiatry. We used this week’s Weekend Reading section, at the end of this bulletin, to share a few…


Previous articlePTSF59 – Bipolar and Psychedelics, with Benjamin Mudge
Next articleMindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial